First Time Loading...

Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 48.79 USD -0.41% Market Closed
Updated: Apr 24, 2024
Section:
 

Relative Value

The Relative Value of one BMY stock under the Base Case scenario is 78.09 USD. Compared to the current market price of 48.79 USD, Bristol-Myers Squibb Co is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BMY Relative Value
Base Case
78.09 USD
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
96
vs Industry
50
Median 3Y
3.1
Median 5Y
3.1
Industry
2.3
Forward
2.1
More Details
12.3
P/E
P/E
Price to Earnings
12.3
vs History
61
vs Industry
35
Median 3Y
16.3
Median 5Y
13.2
Industry
22.2
Forward
7.1
More Details
7.1
P/OCF
P/OCF
Price to OCF
7.1
vs History
96
vs Industry
41
Median 3Y
9.5
Median 5Y
9.7
Industry
16.7
More Details
8.2
P/FCFE
P/FCFE
Price to FCFE
8.2
vs History
76
vs Industry
31
Median 3Y
13.7
Median 5Y
11.1
Industry
22.6
More Details
3.4
P/B
P/B
Price to Book Value
3.4
vs History
73
vs Industry
23
Median 3Y
4
Median 5Y
3.8
Industry
2
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
88
vs Industry
41
Median 3Y
3.7
Median 5Y
3.7
Industry
2.5
Forward
2.7
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
96
vs Industry
54
Median 3Y
4.7
Median 5Y
4.7
Industry
5
More Details
6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6
vs History
96
vs Industry
45
Median 3Y
7.8
Median 5Y
7.9
Industry
13.2
Forward
23
More Details
11.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.4
vs History
80
vs Industry
36
Median 3Y
14.7
Median 5Y
14.8
Industry
16.5
Forward
29.3
More Details
8.9
EV/OCF
EV/OCF
Enterprise Value to OCF
8.9
vs History
90
vs Industry
39
Median 3Y
11.5
Median 5Y
11.4
Industry
15.5
More Details
9.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.7
vs History
92
vs Industry
29
Median 3Y
12.3
Median 5Y
12.1
Industry
17.2
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
76
vs Industry
44
Median 3Y
1.8
Median 5Y
1.8
Industry
1.9
More Details

Multiples Across Competitors

BMY Competitors Multiples
Bristol-Myers Squibb Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bristol-Myers Squibb Co
NYSE:BMY
98.6B USD 2.2 12.3 6 11.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.5B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
356.4B USD 4.4 8.8 11.7 15.5
US
Merck & Co Inc
NYSE:MRK
320.4B USD 5.3 877.9 43.7 85.3
UK
AstraZeneca PLC
LSE:AZN
176B GBP 4.8 36.8 139.6 223.9
CH
Novartis AG
SIX:NOVN
182.3B CHF 4.3 13.5 9.8 16.3
CH
Roche Holding AG
SIX:ROG
176.9B CHF 3 15.4 8.5 10

See Also

Summary
BMY intrinsic value, competitors valuation, and company profile.
DCF Valuation
BMY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BMY stock valuation using valuation multiples.
Wall Street Estimates
BMY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BMY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.